BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube Channel

WOODLAND HILLS, CA / ACCESSWIRE / August 12, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the company's CEO sat down for an interview with The Beast of Wall Street on August 8, 2024 to discuss the past present and future of BioTech Medics, Inc. This interview can be found at the following link: https://x.com/dsalzarulo/status/1821592473652883916?s=46 additionally an excerpt of this interview can be found on the Company's YouTube Channel @Biotech Medics

Foto: Accesswire

According to Anthony K. Miller, CEO, "in preparing this press release there were three (3) issues that troubled me #1 the interview was over 1 hour long; #2 the audio quality was not great even with enhancements #3 nobody has that much time to listen to me ramble about our excellent business opportunity. So, Today I announce our YouTube channel @Biotech Medics and I hope that you listen to some of the videos that I just placed on this channel. They range from our promotional videos to me just recreating excerpts (and topics) from the August 8 interview. This will be a permanent place where we will continue to add content related to our business and operations. My hope is that you hit the Subscribe button and Notification Bell and you will get our videos directly when we upload them. My hope is that these series of press releases and now videos will help you understand our excellent business model that we feel will be a long running and profitable enterprise… commented Miller"

About BioTech Medics, Inc.: BioTech Medics, Inc. (website http://bmcs.company) is a publicly traded Wyoming company traded on the OTC Markets (under the stock symbol BMCS) located in the Los Angeles, California area. Management decided to take the Company back to its biotech roots and did initiate an agreement with certain asset holders in the Dominican Republic with Calcium carbonate reserves. On September 28, 2023 as a result of a negotiated agreement, BioTech Medics received 2 million metric tons of very high quality (99.8% pure) calcium carbonate to market to a worldwide marketplace. This calcium carbonate has a base value of $30 million dollars. Management did procure (along with this transaction) an option to acquire an additional 48 million metric tons of calcium carbonate at a similar transaction value. Our new business plan is an old school commodities plan where we mine our calcium, put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. BMCS is not a Financial Services Company; and Management suggest that potential investors should not use the Companies digital assets, currently on our books. as a calculation to invest in BMCS.